---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-057008"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:11:59.999028+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma receives Nasdaq notice for non-compliance with $1.00 minimum bid price

## Summary
- Received Nasdaq notice on April 29, 2024 for failing to maintain minimum bid price of $1.00 per ADS for 31 consecutive business days through April 26, 2024.
- No immediate effect on listing; ADSs continue trading on Nasdaq Capital Market under symbol QNRX.
- Company has 180 calendar days, until October 28, 2024, to regain compliance by having closing bid price >= $1.00 for at least 10 consecutive business days.
- If not compliant by October 28, may be eligible for a second 180-day period if it meets other initial listing standards.
- Company will monitor bid price and consider available options to cure the deficiency.

## SEC filing metadata
- accession: 0001104659-24-057008
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924057008/0001104659-24-057008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924057008/tm2413391d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-057008
- JSON: https://secwatch.observer/filing/0001104659-24-057008.json
- Plain text: https://secwatch.observer/filing/0001104659-24-057008.txt

## Key facts
- Listing & Compliance Notices
  Quoin Pharmaceuticals, Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: April 29, 2024, Quoin Pharmaceuticals Ltd. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 31 consecutive business days (March 14, 2024 through April 26, 2024), the Company’s American Depositary Shares (“ADSs”) did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per ADS as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s ADSs and the ADSs will continue to trade on Th
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671502/000110465924057008/0001104659-24-057008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.